Reactivation of hepatitis B in a patient with Crohn’s disease treated using infliximab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reactivation of hepatitis B in a patient with Crohn’s disease treated using infliximab

Published:2008-05 Issue:5 Volume:43 Page:397-401
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Ojiro Keisuke,Naganuma Makoto,Ebinuma Hirotoshi,Kunimoto Hiroyoshi,Tada Shinichiro,Ogata Haruhiko,Iwao Yasushi,Saito Hidetsugu,Hibi Toshifumi

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00535-008-2165-x.pdf

Reference21 articles.

1. Candy S, Wright JP, Gerber M, Adams G, Gerig M, Goodman R. A double blind controlled study of azathioprine in the treatment and maintenance of remission in Crohn’s disease. Gut 1995;37:674–678.

2. Ewe K, Press A, Singe C, Stufler M, Ueberschaer B, Hommel G, et al. Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn’s disease. Gastroenterology 1993;105:367–372.

3. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn’s disease with 6-mercaputopurine: a long-term, randomized, double blind study. N Engl J Med 1980;302:981–987.

4. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaputopurine with Crohn’s disease. A meta-analysis. Ann Intern Med 1995;122:132–142.

5. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. Crohn’s Disease cA2 Study Group. N Engl J Med 1997;337:1029–1035.

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunizations in the Child with Inflammatory Bowel Disease;Pediatric Inflammatory Bowel Disease;2023

2. Safety and tolerability of medicinal parasite ova (Trichuris suis) in healthy Japanese volunteers: A randomized, double-blind, placebo-controlled trial;Parasitology International;2021-12

3. CURRENT APPROACH TO HEPATOBILIARY MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE;J PHYSIOL PHARMACOL;2021

4. Common Gastrointestinal Medications Implicated in Drug‐Induced Liver Injury;Clinical Liver Disease;2021-10

5. Vaccination Rates and Family Barriers Among Children with Inflammatory Bowel Disease;Crohn's & Colitis 360;2020-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3